Alkaptonuria Case Study: Enrolling 140 patients in 9 Months

Alkaptonuria Case Study: Enrolling 140 patients in 9 Months

With only 350 known AKU-patients across Europe, PSR needed to enroll 40% of all the patients into a study, in less than one year. Read further to learn how we managed to complete recruitment in just nine months - enrolling patients from 16 different countries,...

See you at the World Orphan Drug Congress USA 2020 Virtual Event

See you at the World Orphan Drug Congress USA 2020 Virtual Event

The PSR Orphan Experts and Ergomed team is looking forward to taking part in the four-day event of the World Orphan Drug Congress USA 2020, taking place in the virtual realm this year. Just like our patients, we recognize that every rare disease clinical trial is...

Wilson’s Disease Case Study “She Said Yes!”

A 32-year old woman, recently diagnosed with Wilson’s Disease, was willing to participate in a clinical trial but had her wedding and three-week long honeymoon arranged for a month after study-enrolment. Read further to learn how, thanks to our team’s proactivity, she...

Press Release – Ergomed H1 2020 Trading Update

Press Release – Ergomed H1 2020 Trading Update

As part of the Ergomed Group, PSR The Orphan Experts is pleased to share the Ergomed H1 2020 Trading Update. ERGOMED PRESS RELEASE EBITDA for FY 2020 expected to be materially ahead of market expectationsIntegrated pharmaceutical services business demonstrates...

See you at Orphan Drugs and Rare Diseases Digital Event (9-10 July)

Ergomed and PSR Orphan Experts are looking forward being a part of Markets and Markets “Digital Event on Orphan Drugs and Rare Diseases” on the 9th -10th July 2020. You can meet up with the PSR & Ergomed team via their contact details below or by sending an email...